Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,782 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical drug development: an analysis of phase II trials, 1970-1985.
Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE. Marsoni S, et al. Among authors: simon r. Cancer Treat Rep. 1987 Jan;71(1):71-80. Cancer Treat Rep. 1987. PMID: 3791270
Application of a human tumor colony-forming assay to new drug screening.
Shoemaker RH, Wolpert-DeFilippes MK, Kern DH, Lieber MM, Makuch RW, Melnick NR, Miller WT, Salmon SE, Simon RM, Venditti JM, et al. Shoemaker RH, et al. Among authors: simon rm. Cancer Res. 1985 May;45(5):2145-53. Cancer Res. 1985. PMID: 3986767
Efficiency of antitumor screening relative to activity criteria.
Paull K, Hodes L, Simon RM. Paull K, et al. Among authors: simon rm. J Natl Cancer Inst. 1986 Jun;76(6):1137-42. J Natl Cancer Inst. 1986. PMID: 3458950
Natural history of malignant lymphomas with divergent histologies at staging evaluation.
Fisher RI, Jones RB, DeVita VT Jr, Simon RM, Garvin AJ, Berard CW, Young RC. Fisher RI, et al. Among authors: simon rm. Cancer. 1981 Apr 15;47(8):2022-5. doi: 10.1002/1097-0142(19810415)47:8<2022::aid-cncr2820470820>3.0.co;2-v. Cancer. 1981. PMID: 7226096
Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC, Waalkes TP, Snyder JJ, Simon RM. Tormey DC, et al. Among authors: simon rm. Cancer. 1977 Jun;39(6):2397-404. doi: 10.1002/1097-0142(197706)39:6<2397::aid-cncr2820390614>3.0.co;2-n. Cancer. 1977. PMID: 872038
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute.
Anderson T, DeVita VT Jr, Simon RM, Berard CW, Canellos GP, Garvin AJ, Young RC. Anderson T, et al. Among authors: simon rm. Cancer. 1982 Dec 15;50(12):2708-21. doi: 10.1002/1097-0142(19821215)50:12<2708::aid-cncr2820501203>3.0.co;2-g. Cancer. 1982. PMID: 7139564
Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.
Mather FJ, Simon RM, Clark GM, Von Hoff DD. Mather FJ, et al. Among authors: simon rm. Cancer Treat Rep. 1987 Jun;71(6):609-13. Cancer Treat Rep. 1987. PMID: 3581099
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
Rosenburg SA, Chabner BA, Young RC, Seipp CA, Levine AS, Costa J, Hanson TA, Head GC, Simon RM. Rosenburg SA, et al. Among authors: simon rm. Cancer Treat Rep. 1979 May;63(5):739-51. Cancer Treat Rep. 1979. PMID: 313245 Clinical Trial.
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
Popp MB, Fisher RI, Simon RM, Brennan MF. Popp MB, et al. Among authors: simon rm. Cancer Treat Rep. 1981;65 Suppl 5:129-35. Cancer Treat Rep. 1981. PMID: 6809322 Clinical Trial.
Tolerance to antineoplastic agents in children and adults.
Marsoni S, Ungerleider RS, Hurson SB, Simon RM, Hammershaimb LD. Marsoni S, et al. Among authors: simon rm. Cancer Treat Rep. 1985 Nov;69(11):1263-9. Cancer Treat Rep. 1985. PMID: 2418966 No abstract available.
2,782 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback